These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 25362251)

  • 1. Dopamine agonist withdrawal syndrome in a patient with restless legs syndrome without impulse control disorder or drug abuse.
    Shimo Y; Nakajima A; Hattori N
    Neurol Sci; 2015 Jun; 36(6):1021-3. PubMed ID: 25362251
    [No Abstract]   [Full Text] [Related]  

  • 2. Dopamine agonist withdrawal syndrome in a patient with restless legs syndrome.
    Dorfman BJ; Nirenberg MJ
    Parkinsonism Relat Disord; 2013 Feb; 19(2):269-70. PubMed ID: 22749683
    [No Abstract]   [Full Text] [Related]  

  • 3. Major depression after withdrawing dopamine agonists in two patients with restless legs syndrome and impulse control disorders.
    Launois C; Leu-Semenescu S; Brion A; Arnulf I
    Sleep Med; 2013 Jul; 14(7):696. PubMed ID: 23714418
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of periodic leg movement disorder and restless leg syndrome with talipexole.
    Inoue Y; Mitani H; Nanba K; Kawahara R
    Psychiatry Clin Neurosci; 1999 Apr; 53(2):283-5. PubMed ID: 10459713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of change in restless legs syndrome symptoms during the acute drug-withdrawal period.
    Wang A; Foster K; Skeba P; Hiranniramol K; Earley CJ; Allen RP
    Sleep Med; 2018 Dec; 52():80-87. PubMed ID: 30286384
    [No Abstract]   [Full Text] [Related]  

  • 6. The emergence of devastating impulse control disorders during dopamine agonist therapy of the restless legs syndrome.
    Dang D; Cunnington D; Swieca J
    Clin Neuropharmacol; 2011; 34(2):66-70. PubMed ID: 21412200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transdermal rotigotine in restless legs syndrome: impulse control disorders.
    Prescrire Int; 2014 Oct; 23(153):239. PubMed ID: 25964969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathologic gambling in patients with restless legs syndrome treated with dopaminergic agonists.
    Tippmann-Peikert M; Park JG; Boeve BF; Shepard JW; Silber MH
    Neurology; 2007 Jan; 68(4):301-3. PubMed ID: 17242339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopaminergic Therapy for Restless Legs Syndrome/Willis-Ekbom Disease.
    Zak RS; Walters AS
    Sleep Med Clin; 2015 Sep; 10(3):279-85, xiii. PubMed ID: 26329437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ropinirole in restless leg syndrome.
    Ahmed I
    Mo Med; 2002; 99(9):500-1. PubMed ID: 12462942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of dopamine agonist in the treatment of restless legs syndrome: caution for practitioners and bipolar patients.
    Buckner AC
    South Med J; 2008 Aug; 101(8):785. PubMed ID: 18622349
    [No Abstract]   [Full Text] [Related]  

  • 12. Dopamine agonist-induced pathological gambling in restless legs syndrome due to multiple sclerosis.
    Evans AH; Butzkueven H
    Mov Disord; 2007 Mar; 22(4):590-1. PubMed ID: 17230484
    [No Abstract]   [Full Text] [Related]  

  • 13. Rotigotine and restless legs syndrome: new indication. The worst dopamine agonist. Just as unsatisfactory; defective design.
    Prescrire Int; 2009 Oct; 18(103):197. PubMed ID: 19882782
    [No Abstract]   [Full Text] [Related]  

  • 14. Liver toxicity possibly related with ropinirole use in the treatment of restless legs syndrome.
    Navacerrada F; González-Alonso MR; Alonso-Navarro H; Pilo-de-la-Fuente B; Plaza-Nieto JF; Jiménez-Jiménez FJ
    Eur J Neurol; 2011 Jun; 18(6):e65. PubMed ID: 21199184
    [No Abstract]   [Full Text] [Related]  

  • 15. Ropinirole (Requip) for restless legs syndrome.
    Med Lett Drugs Ther; 2005 Aug; 47(1214):62-4. PubMed ID: 16052162
    [No Abstract]   [Full Text] [Related]  

  • 16. Pathological gambling associated with dopamine agonist use in restless legs syndrome.
    Quickfall J; Suchowersky O
    Parkinsonism Relat Disord; 2007 Dec; 13(8):535-6. PubMed ID: 17270485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Augmentation and impulsivity in restless legs syndrome patients: A complex interaction.
    O'Sullivan SS; Poyares D
    Neurology; 2016 Jul; 87(1):15-6. PubMed ID: 27261094
    [No Abstract]   [Full Text] [Related]  

  • 18. Controlled withdrawal of pramipexole after 6 months of open-label treatment in patients with restless legs syndrome.
    Trenkwalder C; Stiasny-Kolster K; Kupsch A; Oertel WH; Koester J; Reess J
    Mov Disord; 2006 Sep; 21(9):1404-10. PubMed ID: 16755554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pramipexole (Mirapex) for restless legs syndrome.
    Med Lett Drugs Ther; 2007 Mar; 49(1257):26-8. PubMed ID: 17375031
    [No Abstract]   [Full Text] [Related]  

  • 20. [Ropinirole treatment of restless legs].
    Kinge E; Lossius MI; Mowincel P
    Ugeskr Laeger; 2005 Mar; 167(11):1284-6. PubMed ID: 15830500
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.